UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19

Scientific reports, 2021-01, Vol.11 (1), p.1-12, Article 1930

2021

Volltextzugriff (PDF)

NF-κB oscillations translate into functionally related patterns of gene expression

eLife, 2016-01, Vol.5, p.e09100-e09100

2016

Volltextzugriff (PDF)

Meta-analysis of transcriptomic data reveals clusters of consistently deregulated gene and disease ontologies in Down syndrome

PLoS computational biology, 2021-09, Vol.17 (9), p.e1009317-e1009317

2021

Volltextzugriff (PDF)

The importance of long non-coding RNAs in neuropsychiatric disorders

Molecular aspects of medicine, 2019-12, Vol.70, p.127-140

2019

Volltextzugriff (PDF)

Social Factors Influence Behavior in the Novel Object Recognition Task in a Mouse Model of Down Syndrome

Frontiers in behavioral neuroscience, 2021-11, Vol.15, p.772734-772734

2021

Volltextzugriff (PDF)

Specific Susceptibility to COVID-19 in Adults with Down Syndrome

Neuromolecular medicine, 2021-12, Vol.23 (4), p.561-571

2021

Volltextzugriff (PDF)

DYRK1A Overexpression Alters Cognition and Neural-Related Proteomic Pathways in the Hippocampus That Are Rescued by Green Tea Extract and/or Environmental Enrichment

Frontiers in molecular neuroscience, 2019-11, Vol.12, p.272-272

2019

Volltextzugriff (PDF)

Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome

Frontiers in immunology, 2021-06, Vol.12, p.621440-621440

2021

Volltextzugriff (PDF)

Metabolomics predicts the pharmacological profile of new psychoactive substances

Journal of psychopharmacology (Oxford), 2019-03, Vol.33 (3), p.347-354

2019

Volltextzugriff (PDF)

Proteomic profiling reveals mitochondrial dysfunction in the cerebellum of transgenic mice overexpressing DYRK1A, a Down syndrome candidate gene

Frontiers in molecular neuroscience, 2022-12, Vol.15, p.1015220-1015220

2022

Volltextzugriff (PDF)

Translating molecular advances in Down syndrome and Fragile X syndrome into therapies

European neuropsychopharmacology, 2018-06, Vol.28 (6), p.675-690

2018

Volltextzugriff (PDF)

Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome

Neuromolecular medicine, 2021-12, Vol.23 (4), p.572-573

2021

Volltextzugriff (PDF)

Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome

Neuromolecular medicine, 2021-12, Vol.23 (4), p.574-575

2021

Volltextzugriff (PDF)

A transcriptomic signature of X chromosome overdosage in Saudi Klinefelter syndrome induced pluripotent stem cells

Endocrine Connections, 2023-05, Vol.12 (5), p.1-12

2023

Volltextzugriff (PDF)

Intensive assessment of executive functions derived from performance in cognitive training games

iScience, 2023-06, Vol.26 (6), p.106886-106886, Article 106886

2023

Volltextzugriff (PDF)

Transposable elements in brain health and disease

Ageing research reviews, 2020-12, Vol.64, p.101153, Article 101153

2020

Volltextzugriff (PDF)

Urokinase plasminogen activator mediates changes in human astrocytes modeling fragile X syndrome

Glia, 2021-12, Vol.69 (12), p.2947-2962

2021

Volltextzugriff (PDF)

Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders

European neuropsychopharmacology, 2022-01, Vol.54, p.41-53

2022

Volltextzugriff (PDF)

Exploring the link between hedonic overeating and prefrontal cortex dysfunction in the Ts65Dn trisomic mouse model

Cellular and molecular life sciences : CMLS, 2023-12, Vol.80 (12), p.370-370, Article 370

2023

Volltextzugriff (PDF)

PENSA study for the prevention of cognitive decline in APOE‐ɛ4 carriers with subjective cognitive decline: Description of baseline demographic and neuropsychological data of the study population

Alzheimer's & dementia, 2023-06, Vol.19 (S4), p.n/a

2023

Volltextzugriff (PDF)

Cognitive function and brain structure correlates in individuals with subjective cognitive decline: Voxel‐based morphometry results from a lifestyle intervention to prevent Alzheimer’s disease (PENSA study)

Alzheimer's & dementia, 2023-06, Vol.19 (S4), p.n/a

2023

Volltextzugriff (PDF)

Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review

European neuropsychopharmacology, 2022-02, Vol.55, p.112-157

2022

Volltextzugriff (PDF)

Cardiovascular Risk Factors and Cognition in Older Adults at High Risk of Alzheimer’s Disease Following a Lifestyle Multimodal Intervention: An Assessment of the PENSA Study

Current developments in nutrition, 2022-06, Vol.6, p.783-783

2022

Volltextzugriff (PDF)

Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability Disorders

Neural plasticity, 2016-01, Vol.2016 (2016), p.1-20

2016

Volltextzugriff (PDF)

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study

Targeted oncology, 2024-05, Vol.19 (3), p.359-370

2024

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19

NF-κB oscillations translate into functionally related patterns of gene expression

Meta-analysis of transcriptomic data reveals clusters of consistently deregulated gene and disease ontologies in Down syndrome

The importance of long non-coding RNAs in neuropsychiatric disorders

Social Factors Influence Behavior in the Novel Object Recognition Task in a Mouse Model of Down Syndrome

Specific Susceptibility to COVID-19 in Adults with Down Syndrome

DYRK1A Overexpression Alters Cognition and Neural-Related Proteomic Pathways in the Hippocampus That Are Rescued by Green Tea Extract and/or Environmental Enrichment

Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome

Metabolomics predicts the pharmacological profile of new psychoactive substances

Proteomic profiling reveals mitochondrial dysfunction in the cerebellum of transgenic mice overexpressing DYRK1A, a Down syndrome candidate gene

Translating molecular advances in Down syndrome and Fragile X syndrome into therapies

Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome

Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome

A transcriptomic signature of X chromosome overdosage in Saudi Klinefelter syndrome induced pluripotent stem cells

Intensive assessment of executive functions derived from performance in cognitive training games

Transposable elements in brain health and disease

Urokinase plasminogen activator mediates changes in human astrocytes modeling fragile X syndrome

Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders

Exploring the link between hedonic overeating and prefrontal cortex dysfunction in the Ts65Dn trisomic mouse model

PENSA study for the prevention of cognitive decline in APOE‐ɛ4 carriers with subjective cognitive decline: Description of baseline demographic and neuropsychological data of the study population

Cognitive function and brain structure correlates in individuals with subjective cognitive decline: Voxel‐based morphometry results from a lifestyle intervention to prevent Alzheimer’s disease (PENSA study)

Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review

Cardiovascular Risk Factors and Cognition in Older Adults at High Risk of Alzheimer’s Disease Following a Lifestyle Multimodal Intervention: An Assessment of the PENSA Study

Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability Disorders

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study

Suchergebnisse filtern